drugset / Trial / NCT05447364

Efficacy of Different Doses of Pregabalin as a Multimodal Analgesic Agent in Postoperative Pain Control After Total Knee Arthroplasty

NCT05447364

Phase 4 Completed 82 enrolled Thammasat University
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare the efficacy of 75 mg of Pregabalin and 150 mg of Pregabalin in postoperative pain control after TKA.

Timeline

Start
2021-07-01
Primary completion
2023-09-01
Completion
2024-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 75 mg
Subject Pregabalin Small molecule 150 mg

Indications